Collagen vascular disease in the lungs

More documents

Recommendations

Info

Prognostic Algorithm Easy to apply in clinical practice Still needs to be validated HR 3.5 vs. 2.5 (HRCT)or 2.1 (FVC) Goh et al. AJRCCM 2008; 177: 1248-54
6MWT & Prognosis: IPF • Safe • Simple, convenient & inexpensive • Reproducible • Strong & independent predictor of survival time • NB. desaturation to
Page 1 and 2: COLLAGEN VASCULAR DISEASE IN THE LU
Page 3 and 4: Forms of Lung Disease in CVD • In
Page 5 and 6: ILD IN COLLAGEN VASCULAR DISEASE (C
Page 7 and 8: Antoniou et al. ERJ 2009; 33: 882-9
Page 9 and 10: NSIP: CXR • Bilateral • Fine re
Page 11 and 12: HRCT: UIP vs. NSIP
Page 13 and 14: Mean survivals of patients: HRCT di
Page 15 and 16: Background ILD common in SSc: 75% (
Page 17 and 18: CXR Limited value Imaging HRCT Very
Page 19 and 20: Serial PFTs & Prognosis: IPF Bad Pr
Page 21: Prognostic Algorithm Used 215 SSc-I
Page 25 and 26: SSc: Exercise Testing CPEX has been
Page 27 and 28: Therapy 1) Prednisone ?? renal cris
Page 29 and 30: RHEUMATOID ARTHRITIS (RA)
Page 31 and 32: RA-ILD worse prognosis than other C
Page 33 and 34: PFTs Good at picking up lung diseas
Page 35 and 36: Therapy No randomised controlled tr
Page 37 and 38: ILD uncommon in SLE: Background •
Page 39 and 40: Lung Biopsy Not often done CIP: NSI
Page 41: Pulmonary Approach to CVD Patients

Collagen vascular disease in the lungs

Create successful ePaper yourself

Delete template?

Save as template?